Receipt of opioid use disorder treatments prior to fatal overdoses and comparison to no treatment in Connecticut, 2016–17
Open Access
- 27 November 2023
- journal article
- research article
- Published by Elsevier in Drug and Alcohol Dependence
- Vol. 254, 111040
Abstract
No abstract availableKeywords
Funding Information
- U.S. Food and Drug Administration (U01FD005938)
- National Institute on Drug Abuse (5K12DA033312)
- Office of the Chief Medical Examiner
- Ohio Department of Mental Health and Addiction Services
- Centers for Disease Control and Prevention (1 NU1ROT000012-01)
This publication has 27 references indexed in Scilit:
- Injectable naltrexone, oral naltrexone, and buprenorphine utilization and discontinuation among individuals treated for opioid use disorder in a United States commercially insured populationJournal of Substance Abuse Treatment, 2018
- Prescribing patterns of buprenorphine waivered physiciansDrug and Alcohol Dependence, 2017
- Mortality risk during and after opioid substitution treatment: systematic review and meta-analysis of cohort studiesBMJ, 2017
- Reducing rates of preventable HIV/AIDS-associated mortality among people living with HIV who inject drugsCurrent Opinion in HIV and AIDS, 2016
- Rising morbidity and mortality in midlife among white non-Hispanic Americans in the 21st centuryProceedings of the National Academy of Sciences, 2015
- Patterns and Quality of Buprenorphine Opioid Agonist Treatment in a Large Medicaid ProgramJournal of Addiction Medicine, 2015
- Record linkage software in the public domain: a comparison of Link Plus, The Link King, and a `basic' deterministic algorithmHealth Informatics Journal, 2008
- Loss of tolerance and overdose mortality after inpatient opiate detoxification: follow up studyBMJ, 2003
- Inpatient opiate detoxification in Geneva: follow-up at 1 and 6 monthsDrug and Alcohol Dependence, 2000
- Mortality among HIV-infected intravenous drug addicts in Stockholm in relation to methadone treatmentAddiction, 1995